Botulinum Toxin Type A For Gummy Smile By Muscle Hyperfunction

Detalhes bibliográficos
Autor(a) principal: Muknicka, Daniella Pilon
Data de Publicação: 2022
Outros Autores: Roman-Torres, Caio V G, Marão, Heloísa Fonseca, Boaro, Letícia Cidreira, Bassoukou, Cristine Haralambos, Sendyk, Wilson Roberto, Pimentel, Angélica Castro
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/27397
Resumo: Objective This study aimed to evaluate the action of botulinum toxin type A for mixed gingival smile due to muscle hyperfunction in a female and male sample (n=5) who had 3mm or more of keratinized gingival tissue exposure in a habitual smile. Materials and Methods The protocol used was the application of 8 units of Botulifit® brand Botulinum toxin type A, 2 units in each point, totaling 4 points and 8 units bilaterally. Photographic protocol was established, before and after the procedure, to exemplify the quantitative improvement of gingival exposure and the results of the work. Results The results were evaluated after 30 days (T1) and 5 months (T2) of application, indicating, for the whole sample, a decrease in gingival exposure by the protocol used, even 5 months after the application of botulinum toxin. Conclusion It was concluded from this work that the application of 8 units of botulinum toxin type A is an efficient therapeutic method for the clinical correction of mixed gingival smile due to muscle hyperfunction, presenting little risk of adverse reactions, low pain sensation to puncture and high acceptability of the patient, as its action is temporary and atraumatic.
id UNIFEI_94f1fb47c3c142804d47e63158063bc4
oai_identifier_str oai:ojs.pkp.sfu.ca:article/27397
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Botulinum Toxin Type A For Gummy Smile By Muscle HyperfunctionToxina Botulínica Tipo A Para La Sonrisa Gingival Por Hiperfunción MuscularToxina Botulínica tipo A para Sorriso Gengival por Hipercontração muscularBotulinum Toxin, Type ASmileGingiva.Toxixna Botulínica Tipo ASonrisaChicle.Toxina Botulínica Tipo ASorrisoGengiva.Objective This study aimed to evaluate the action of botulinum toxin type A for mixed gingival smile due to muscle hyperfunction in a female and male sample (n=5) who had 3mm or more of keratinized gingival tissue exposure in a habitual smile. Materials and Methods The protocol used was the application of 8 units of Botulifit® brand Botulinum toxin type A, 2 units in each point, totaling 4 points and 8 units bilaterally. Photographic protocol was established, before and after the procedure, to exemplify the quantitative improvement of gingival exposure and the results of the work. Results The results were evaluated after 30 days (T1) and 5 months (T2) of application, indicating, for the whole sample, a decrease in gingival exposure by the protocol used, even 5 months after the application of botulinum toxin. Conclusion It was concluded from this work that the application of 8 units of botulinum toxin type A is an efficient therapeutic method for the clinical correction of mixed gingival smile due to muscle hyperfunction, presenting little risk of adverse reactions, low pain sensation to puncture and high acceptability of the patient, as its action is temporary and atraumatic.Objetivo Este estudio tuvo como objetivo evaluar la acción de la toxina botulínica tipo A para la sonrisa gingival mixta por hiperfunción muscular en una muestra femenina y masculina (n=5) que tenían 3 mm o más de exposición de tejido gingival queratinizado en una sonrisa habitual. Materiales y Métodos El protocolo utilizado fue la aplicación de 8 unidades de toxina botulínica tipo A marca Botulifit®, 2 unidades en cada punto, totalizando 4 puntos y 8 unidades bilateralmente. Se estableció un protocolo fotográfico, antes y después del procedimiento, para ejemplificar la mejora cuantitativa de la exposición gingival y los resultados del trabajo. Resultados Los resultados fueron evaluados a los 30 días (T1) y 5 meses (T2) de la aplicación, indicando, para toda la muestra, una disminución de la exposición gingival por el protocolo utilizado, incluso 5 meses después de la aplicación de la toxina botulínica. Conclusión Se concluyó de este trabajo que la aplicación de 8 unidades de toxina botulínica tipo A es un método terapéutico eficaz para la corrección clínica de la sonrisa gingival mixta por hiperfunción muscular, presentando poco riesgo de reacciones adversas, baja sensación de dolor a la punción y alta aceptabilidad del paciente, ya que su acción es temporal y atraumática.Objetivo Este trabalho se propôs avaliar a ação da toxina botulínica tipo A para o sorriso gengival misto por hiperfunção muscular em uma amostra do gênero feminino e masculino (n=5) que apresentavam 3mm ou mais de exposição de tecido gengival queratinizado em um sorriso habitual. Materiais e Métodos Utilizou-se como protocolo, a aplicação de 8 unidades de toxina botulínica tipo A da marca Botulifit®, sendo 2 unidades em cada ponto, totalizando 4 pontos e 8 unidades bilateralmente. Protocolo fotográfico foi instituído, antes e após o procedimento, a fim de exemplificar a melhora quantitativa da exposição gengival e os resultados do trabalho. Resultados Os resultados foram avaliados após 30 dias (T1) e 5 meses (T2) de aplicação, indicando, para toda a amostra a diminuição da exposição gengival pelo protocolo utilizado, mesmo 5 meses após a aplicação da toxina botulínica. Conclusão Concluiu-se com esse trabalho, que a aplicação de 8 unidades de toxina botulínica tipo A é um método terapêutico eficiente para correção clínica do sorriso gengival misto por hiperfunção muscular, apresentando pouco risco de reações adversas, baixa sensação dolorosa à punção e alta aceitabilidade do paciente, visto que sua ação é temporária e atraumática.Research, Society and Development2022-03-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2739710.33448/rsd-v11i4.27397Research, Society and Development; Vol. 11 No. 4; e31811427397Research, Society and Development; Vol. 11 Núm. 4; e31811427397Research, Society and Development; v. 11 n. 4; e318114273972525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/27397/23949Copyright (c) 2022 Daniella Pilon Muknicka; Caio V G Roman-Torres; Heloísa Fonseca Marão; Letícia Cidreira Boaro; Cristine Haralambos Bassoukou; Wilson Roberto Sendyk; Angélica Castro Pimentelhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMuknicka, Daniella Pilon Roman-Torres, Caio V GMarão, Heloísa Fonseca Boaro, Letícia Cidreira Bassoukou, Cristine Haralambos Sendyk, Wilson Roberto Pimentel, Angélica Castro 2022-03-27T17:17:09Zoai:ojs.pkp.sfu.ca:article/27397Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:45:08.935177Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Botulinum Toxin Type A For Gummy Smile By Muscle Hyperfunction
Toxina Botulínica Tipo A Para La Sonrisa Gingival Por Hiperfunción Muscular
Toxina Botulínica tipo A para Sorriso Gengival por Hipercontração muscular
title Botulinum Toxin Type A For Gummy Smile By Muscle Hyperfunction
spellingShingle Botulinum Toxin Type A For Gummy Smile By Muscle Hyperfunction
Muknicka, Daniella Pilon
Botulinum Toxin, Type A
Smile
Gingiva.
Toxixna Botulínica Tipo A
Sonrisa
Chicle.
Toxina Botulínica Tipo A
Sorriso
Gengiva.
title_short Botulinum Toxin Type A For Gummy Smile By Muscle Hyperfunction
title_full Botulinum Toxin Type A For Gummy Smile By Muscle Hyperfunction
title_fullStr Botulinum Toxin Type A For Gummy Smile By Muscle Hyperfunction
title_full_unstemmed Botulinum Toxin Type A For Gummy Smile By Muscle Hyperfunction
title_sort Botulinum Toxin Type A For Gummy Smile By Muscle Hyperfunction
author Muknicka, Daniella Pilon
author_facet Muknicka, Daniella Pilon
Roman-Torres, Caio V G
Marão, Heloísa Fonseca
Boaro, Letícia Cidreira
Bassoukou, Cristine Haralambos
Sendyk, Wilson Roberto
Pimentel, Angélica Castro
author_role author
author2 Roman-Torres, Caio V G
Marão, Heloísa Fonseca
Boaro, Letícia Cidreira
Bassoukou, Cristine Haralambos
Sendyk, Wilson Roberto
Pimentel, Angélica Castro
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Muknicka, Daniella Pilon
Roman-Torres, Caio V G
Marão, Heloísa Fonseca
Boaro, Letícia Cidreira
Bassoukou, Cristine Haralambos
Sendyk, Wilson Roberto
Pimentel, Angélica Castro
dc.subject.por.fl_str_mv Botulinum Toxin, Type A
Smile
Gingiva.
Toxixna Botulínica Tipo A
Sonrisa
Chicle.
Toxina Botulínica Tipo A
Sorriso
Gengiva.
topic Botulinum Toxin, Type A
Smile
Gingiva.
Toxixna Botulínica Tipo A
Sonrisa
Chicle.
Toxina Botulínica Tipo A
Sorriso
Gengiva.
description Objective This study aimed to evaluate the action of botulinum toxin type A for mixed gingival smile due to muscle hyperfunction in a female and male sample (n=5) who had 3mm or more of keratinized gingival tissue exposure in a habitual smile. Materials and Methods The protocol used was the application of 8 units of Botulifit® brand Botulinum toxin type A, 2 units in each point, totaling 4 points and 8 units bilaterally. Photographic protocol was established, before and after the procedure, to exemplify the quantitative improvement of gingival exposure and the results of the work. Results The results were evaluated after 30 days (T1) and 5 months (T2) of application, indicating, for the whole sample, a decrease in gingival exposure by the protocol used, even 5 months after the application of botulinum toxin. Conclusion It was concluded from this work that the application of 8 units of botulinum toxin type A is an efficient therapeutic method for the clinical correction of mixed gingival smile due to muscle hyperfunction, presenting little risk of adverse reactions, low pain sensation to puncture and high acceptability of the patient, as its action is temporary and atraumatic.
publishDate 2022
dc.date.none.fl_str_mv 2022-03-19
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/27397
10.33448/rsd-v11i4.27397
url https://rsdjournal.org/index.php/rsd/article/view/27397
identifier_str_mv 10.33448/rsd-v11i4.27397
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/27397/23949
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 4; e31811427397
Research, Society and Development; Vol. 11 Núm. 4; e31811427397
Research, Society and Development; v. 11 n. 4; e31811427397
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052835258433536

Registros relacionados